EPO and Miyoshi myopathy: To accurately predict recurrence of VTE, patients at high risk of recurrence may require prolonged anticoagulant therapy. Dalteparin can be used to treat VTE in MM patients. In addition, higher hemoglobin levels and concurrent EPO use were linked to increased risk of recurrence, recommending cautious use until VTE is fully cured. As a surrogate for VTE in MM patients, D-dimer levels changed significantly before and after dalteparin therapy.